Patents by Inventor Timothy A. Holden

Timothy A. Holden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Buprenorphine-wafer for drug substitution therapy
    Publication number: 20190216797
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Application
    Filed: August 17, 2018
    Publication date: July 18, 2019
    Inventors: Alexander Oksche, William Heath, Timothy Holden, Derek A. Prater, Richard S. Sackler, Malcolm Walden
  • BUPRENORPHINE WAFER FOR DRUG SUBSTITUTION THERAPY
    Publication number: 20180008595
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Application
    Filed: September 19, 2017
    Publication date: January 11, 2018
    Inventors: Alexander OKSCHE, William HEATH, Timothy HOLDEN, Derek A. PRATER, Richard S. SACKLER, Malcolm WALDEN
  • Buprenorphine-wafer for drug substitution therapy
    Patent number: 9861628
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: January 9, 2018
    Assignee: RHODES PHARMACEUTICALS L.P.
    Inventors: Alexander Oksche, William Heath, Timothy Holden, Derek A. Prater, Richard S. Sackler, Malcolm Walden
  • Buprenorphine-wafer for drug substitution therapy
    Patent number: 9763931
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: September 19, 2017
    Assignee: PURDUE PHARMA L.P.
    Inventors: Alexander Oksche, William Heath, Timothy Holden, Derek A. Prater, Richard S. Sackler, Malcolm Walden
  • Buprenorphine-Wafer for Drug Substitution Therapy
    Publication number: 20170157062
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Application
    Filed: February 24, 2017
    Publication date: June 8, 2017
    Inventors: Alexander OKSCHE, William HEATH, Timothy HOLDEN, Derek A. PRATER, Richard S. SACKLER, Malcolm WALDEN
  • BUPRENORPHINE WAFER FOR DRUG SUBSTITUTION THERAPY
    Publication number: 20160235739
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Application
    Filed: April 22, 2016
    Publication date: August 18, 2016
    Inventors: Alexander OKSCHE, William HEATH, Timothy HOLDEN, Derek A. PRATER, Richard S. SACKLER, Malcolm WALDEN
  • Buprenorphine-wafer for drug substitution therapy
    Publication number: 20160235738
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Application
    Filed: April 22, 2016
    Publication date: August 18, 2016
    Inventors: Alexander OKSCHE, William HEATH, Timothy HOLDEN, Derek A. PRATER, Richard S. SACKLER, Malcolm WALDEN
  • Buprenorphine-wafer for drug substitution therapy
    Patent number: 9370512
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: June 21, 2016
    Assignee: PURDUE PHARMA L.P.
    Inventors: Alexander Oksche, William Heath, Timothy Holden, Derek A. Prater, Richard S. Sackler, Malcolm Walden
  • Buprenorphine-Wafer for Drug Substitution Therapy
    Publication number: 20150328143
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Application
    Filed: July 15, 2015
    Publication date: November 19, 2015
    Inventors: Alexander OKSCHE, William HEATH, Timothy HOLDEN, Derek A. PRATER, Richard S. SACKLER, Malcolm WALDEN
  • Buprenorphine-wafer for drug substitution therapy
    Patent number: 9101625
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Grant
    Filed: August 29, 2007
    Date of Patent: August 11, 2015
    Assignee: PURDUE PHARMA L.P.
    Inventors: Alexander Oksche, William Heath, Timothy Holden, Derek A. Prater, Richard S. Sackler, Malcolm Walden
  • Buprenorphine-Wafer for Drug Substitution Therapy
    Publication number: 20150025102
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 22, 2015
    Inventors: Alexander OKSCHE, William HEATH, Timothy HOLDEN, Derek A. PRATER, Richard S. SACKLER, Malcolm WALDEN
  • Aircraft position light assembly
    Patent number: 8439540
    Abstract: An aircraft position light assembly having one or more light emitting diode (LED) modules. The LED module can be installed in a variety of aircraft wing-tip cavities. An example LED module includes a support device that mounts within an aircraft wingtip, a bracket device that attaches to the support device, at least one circuit board that mounts to the bracket, and two pairs of LEDs. Each pair of LEDs is mounted on opposing major surfaces at a first end of the circuit board. A first pair of reflectors is attached to the circuit board adjacent to two of the LEDs on the opposing major surfaces. A second pair of reflectors is attached to the circuit board adjacent to the other two LEDs on the opposing major surfaces.
    Type: Grant
    Filed: June 3, 2010
    Date of Patent: May 14, 2013
    Assignee: Honeywell International Inc.
    Inventors: Bo Stout, Timothy A. Holden, Kenneth Colvin, Richard Walker, John Lundberg
  • AIRCRAFT POSITION LIGHT ASSEMBLY
    Publication number: 20110299293
    Abstract: An aircraft position light assembly having one or more light emitting diode (LED) modules. The LED module can be installed in a variety of aircraft wing-tip cavities. An example LED module includes a support device that mounts within an aircraft wingtip, a bracket device that attaches to the support device, at least one circuit board that mounts to the bracket, and two pairs of LEDs. Each pair of LEDs is mounted on opposing major surfaces at a first end of the circuit board. A first pair of reflectors is attached to the circuit board adjacent to two of the LEDs on the opposing major surfaces. A second pair of reflectors is attached to the circuit board adjacent to the other two LEDs on the opposing major surfaces.
    Type: Application
    Filed: June 3, 2010
    Publication date: December 8, 2011
    Applicant: HONEYWELL INTERNATIONAL INC.
    Inventors: Bo Stout, Timothy A. Holden, Kenneth Colvin, Richard Walker, John Lundberg
  • Buprenorphine-Wafer for Drug Substitution Therapy
    Publication number: 20100087470
    Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.
    Type: Application
    Filed: August 29, 2007
    Publication date: April 8, 2010
    Applicant: EURO-CELTIQUE S.A.
    Inventors: Alexander Oksche, William Heath, Timothy Holden, Derek A. Prater, Richard S. Sackler, Malcolm Walden